BF
NVAX icon

BOK Financial’s Novavax NVAX Stock Holding History

BOK Financial’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,623
Closed -$284K – 929
2022
Q3 		$284K Buy
+15,623
New +$677K 0.01% 768
2022
Q2 		– Sell
-3,049
Closed -$225K – 955
2022
Q1 		$225K Buy
3,049
+216
+8% +$19.3K ﹤0.01% 897
2021
Q4 		$405K Sell
2,833
-1,991
-41% -$342K 0.01% 755
2021
Q3 		$1M Buy
+4,824
New +$1.06M 0.02% 571
2021
Q1 		– Sell
-2,491
Closed -$278K – 935
2020
Q4 		$278K Sell
2,491
-81
-3% -$8.61K 0.01% 787
2020
Q3 		$278K Buy
+2,572
New +$313K 0.01% 737

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HIG
Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BOK Financial's NVAX Position: Q4 2022 in Review

BOK Financial sold out of Novavax (NVAX) in Q4 2022, closing a stake of 15,623 shares — an estimated $284K sold.

BOK Financial first reported a position in NVAX in Q3 2020 and held it in 6 quarters. The position peaked at $1M in Q3 2021. 252 funds tracked by Wall St. Rank hold NVAX as of Q4 2022.

  • BOK Financial reported no remaining Novavax position as of Q4 2022 after selling out during the quarter.
  • BOK Financial sold 15,623 Novavax shares in Q4 2022, an estimated $284K.
  • BOK Financial first reported a position in Novavax in Q3 2020 and held it in 6 quarters.
  • BOK Financial's Novavax position peaked at $1M in Q3 2021.
  • 252 funds tracked by Wall St. Rank held Novavax as of Q4 2022.

Based on BOK Financial's 13F filing for Q4 2022, filed 13 Feb 2023.